Upper airway.4: Sarcoidosis of the upper respiratory tract (SURT)

Thorax

Volumn 65, Issue 2, 2010, Pages 181-186

  Baughman, Robert P ^a   Lower, Elyse E ^b   Tami, Thomas ^c  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b Oncology Hematolgy Care   (United States)

^c Cincinnati Sinus Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; HYDROXYCHLOROQUINE; METHOTREXATE; THALIDOMIDE;

ARTICLE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; SARCOIDOSIS; UPPER RESPIRATORY TRACT; WEGENER GRANULOMATOSIS;

EID: 76549102486     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.112896     Document Type: Review

References (35)

1. Zeitlin JF, Tami TA, Baughman R, et al. Nasal and sinus manifestations of sarcoidosis. Am J Rhinol 2000;14:157-61.
2. Wilson R, Lund V, Sweatman M, et al. Upper respiratory tract involvement in sarcoidosis and its management. Eur Respir J 1988;1:269-72.
3. Aubart FC, Ouayoun M, Brauner M, et al. Sinonasal involvement in sarcoidosis: a caseecontrol study of 20 patients. Medicine (Baltimore) 2006;85:365-71.
4. Braun JJ, Gentine A, Pauli G. Sinonasal sarcoidosis: review and report of fifteen cases. Laryngoscope 2004;114:1960-3.
5. Sims HS, Thakkar KH. Airway involvement and obstruction from granulomas in African-American patients with sarcoidosis. Respir Med 2007;101:2279-83.
6. Neville E, Mills RG, Jash DK, et al. Sarcoidosis of the upper respiratory tract and its association with lupus pernio. Thorax 1976;31:660-4.
7. Chambellan A, Turbie P, Nunes H, et al. Endoluminal stenosis of proximal bronchi in sarcoidosis: bronchoscopy, function, and evolution. Chest 2005;127:472-81.
8. Udwadia ZF, Pilling JR, Jenkins PF, et al. Bronchoscopic and bronchographic findings in 12 patients with sarcoidosis and severe or progressive airways obstruction. Thorax 1990;45:272-5.
9. Shorr AF, Torrington KG, Hnatiuk OW. Endobronchial biopsy for sarcoidosis: a prospective study. Chest 2001;120:109-14.
10. Naccache JM, Lavole A, Nunes H, et al. High-resolution computed tomographic imaging of airways in sarcoidosis patients with airflow obstruction. J Comput Assist Tomogr 2008;32:905-12.
11. Baughman RP, Judson MA, Teirstein AS, et al. Thalidomide for chronic sarcoidosis. Chest 2002;122:227-32.
12. Hasni SA, Gruber BL. Sarcoidosis presenting as necrotizing sinus destruction mimicking Wegener's granulomatosis. J Rheumatol 2000;27:512-4.
13. Poate TW, Sharma R, Moutasim KA, et al. Orofacial presentations of sarcoidosis - a case series and review of the literature. Br Dent J 2008;205:437-42.
14. Baughman RP, du Bois RM, Lower EE. Sarcoidosis. Lancet 2003;361:1111-8.
15. deShazo RD, O'Brien MM, Justice WK, et al. Diagnostic criteria for sarcoidosis of the sinuses. J Allergy Clin Immunol 1999;103:789-95.
16. Slart RH, Jager PL, Poot L, et al. Clinical value of gallium-67 scintigraphy in assessment of disease activity in Wegener's granulomatosis. Ann Rheum Dis 2003;62:659-62.
17. Fuchs HA, Tanner SB. Granulomatous disorders of the nose and paranasal sinuses. Curr Opin Otolaryngol Head Neck Surg 2009;17:23-7.
18. DeRemee RA. Sarcoidosis and Wegener's granulomatosis: a comparative analysis. Sarcoidosis 1994;11:7-18.
19. Baum ED, Boudousquie AC, Li S, et al. Sarcoidosis with nasal obstruction and septal perforation. Ear Nose Throat J 1998;77:896-2.
20. Bullen CL, Liesegang TJ, McDonald TJ, et al. Ocular complications of Wegener's granulomatosis. Ophthalmology 1983;90:279-90.
21. Comfere NI, Macaron NC, Gibson LE. Cutaneous manifestations of Wegener's granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status. J Cutan Pathol 2007;34:739-47.
22. Baughman RP, Shipley R, Desai S, et al. Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation. Chest 2009;136:526-35.
23. Niimi H, Kang EY, Kwong JS, et al. CT of chronic infiltrative lung disease: prevalence of mediastinal lymphadenopathy. J Comput Assist Tomogr 1996;20:305-8.
24. Lower EE, Weiss KL. Neurosarcoidosis. Clin Chest Med 2008;29:475-92.
25. de Groot K, Schmidt DK, Arlt AC, et al. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol 2001;58:1215-21.
26. Daum TE, Specks U, Colby TV, et al. Tracheobronchial involvement in Wegener's granulomatosis. Am J Respir Crit Care Med 1995;151:522-6.
27. Finkielman JD, Lee AS, Hummel AM, et al. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis. Am J Med 2007;120:643-14.
28. Baughman RP, Costabel U, du Bois RM. Treatment of sarcoidosis. Clin Chest Med 2008;29:533-48.
29. Krespi YP, Kuriloff DB, Aner M. Sarcoidosis of the sinonasal tract: a new staging system. Otolaryngol Head Neck Surg 1995;112:221-7.
30. Fergie N, Jones NS, Havlat MF. The nasal manifestations of sarcoidosis: a review and report of eight cases. J Laryngol Otol 1999;113:893-8.
31. Spiteri MA, Matthey F, Gordon T, et al. Lupus pernio: a clinico-radiological study of thirty-five cases. Br J Dermatol 1985;112:315-22.
32. Stagaki E, Mountford WK, Lackland DT, et al. The treatment of lupus pernio: results of 116 treatment courses in 54 patients. Chest 2009;135:468-76.
33. Kay DJ, Har-El G. The role of endoscopic sinus surgery in chronic sinonasal sarcoidosis. Am J Rhinol 2001;15:249-54.
34. Fouty BW, Pomeranz M, Thigpen TP, et al. Dilatation of bronchial stenoses due to sarcoidosis using a flexible fiberoptic bronchoscope. Chest 1994;106:677-80.
35. Iles PB. Multiple bronchial stenoses: treatment by mechanical dilatation. Thorax 1981;36:784-6.